Concepedia

Mariana Bleker de Oliveira

MB

Statistics

Publications

6

Citations

159

H-Index

6

Active since

2016

Affiliations

Universidade Federal de São Paulo(Current)

Universidade de São Paulo

Instituto do Câncer do Estado de São Paulo

Mariana Bleker de Oliveira is an author at Universidade Federal de São Paulo specializing in oncology, multiple myeloma, and molecular oncology.

ORCID

Publications per year

2016–2019

6

Publications

6

Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients

Mariana Bleker de Oliveira, Veruska L. Fook-Alves, Angela Isabel Pereira Eugênio et al. · Cancer Letters · 2017 · 37 citations

, , +14

TP53 Regulated Inhibitor of Apoptosis 1 (TRIAP1) stable silencing increases late apoptosis by upregulation of caspase 9 and APAF1 in RPMI8226 multiple myeloma cell line

Veruska L. Fook-Alves, Mariana Bleker de Oliveira, Daniela B. Zanatta et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 28 citations

, , +15

Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism

Rodrigo Carlini Fernando, Diego R. Mazzotti, Hátylas Azevedo et al. · Scientific Reports · 2019 · 26 citations · Full text

, , +15

Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly

Wagner A. Poles, Érika E. Nishi, Mariana Bleker de Oliveira et al. · Cancer Immunology Immunotherapy · 2018 · 25 citations · Full text

, , +12

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma

Angela Isabel Pereira Eugênio, Veruska L. Fook-Alves, Mariana Bleker de Oliveira et al. · Oncotarget · 2017 · 22 citations · Full text

, , +13

1–5 of 6